These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5295696)

  • 1. [Experiences of the sports physician with Vertebran in myalgias].
    Landauer W
    Landarzt; 1965 Oct; 41(30):1311-3. PubMed ID: 5295696
    [No Abstract]   [Full Text] [Related]  

  • 2. [Some thoughts on problems in sport medicine. Answer to the article "Sportmedical experience with Vertebran in myalgia" by Dr. W. Landauer. Landarzt, vol. 30, 1965].
    Weidemann H
    Landarzt; 1966 Feb; 42(6):255-7. PubMed ID: 5962382
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of methoxy-naphthyl-propionic acid in sports medicine].
    Falai G; Veronesi PL; Palazzini E
    Clin Ter; 1980 Oct; 95(1):59-70. PubMed ID: 6970647
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of drugs in rheumatic diseases.
    Gall EP
    Prim Care; 1984 Jun; 11(2):369-80. PubMed ID: 6433371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experiences with Scutamil C in locomotor system disorders].
    Bednarík J; Pracke T; Pĕgrrímová E; Vykydal M
    Fysiatr Revmatol Vestn; 1972 Dec; 50(6):339-42. PubMed ID: 4565253
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combination of analgesics and cortisone in the treatment of rheumatic disease].
    SCHIAVETTI L; VERZOLINI V
    Policlinico Prat; 1957 Jun; 64(25):922-8. PubMed ID: 13452903
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with a new antirheumatic agent].
    Nixdorf G
    Med Welt; 1965 Jul; 31():1763-4. PubMed ID: 5294409
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the treatment of inflammatory and degenerative diseases of the musculosketetal system with Vertebran].
    Rölke HW
    Dtsch Med J; 1968 Dec; 19(23):836-40. PubMed ID: 4975218
    [No Abstract]   [Full Text] [Related]  

  • 9. [The importance of enzymes in the treatment of rheumatic diseases].
    Kullich W
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 9():S316-8. PubMed ID: 19085661
    [No Abstract]   [Full Text] [Related]  

  • 10. Choice of analgesics for rheumatic disorders.
    Rep Rheum Dis; 1968 Jun; 33():1-2. PubMed ID: 5301501
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study of the effects of the topical use of DF-307].
    Rivadeneyra F
    Medicina (Mex); 1965 Oct; 45(974):514-7. PubMed ID: 5295350
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pain and its therapy in rheumatic diseases].
    Dudley Hart F
    Clin Ter; 1968 Feb; 44(3):197-204. PubMed ID: 5308162
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bencyclane in the therapy of diseases of motor organs].
    Dellamartina F
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1448+. PubMed ID: 5312435
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of antirheumatic agents and analgesics in old age in chronic rheumatic disorders].
    Apostoloff E
    Z Arztl Fortbild (Jena); 1982 Apr; 76(8):328-30. PubMed ID: 6981261
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug therapy in rheumatic disease.
    Hill J
    Nursing (Lond); 1984 Nov; 2(31):905-8. PubMed ID: 6334826
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-inflammatory drugs in the treatment of rheumatic diseases.
    Hart FD
    Practitioner; 1970 Nov; 205(229):597-603. PubMed ID: 5312818
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with azapropazone in surgery].
    Vokner J
    Schweiz Rundsch Med Prax; 1970 Dec; 59(50):1756-8. PubMed ID: 5312851
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of myopathic carnitine deficiency: quantitation of response to prednisone and carnitine.
    Griggs RC; Pandya S; Moxley RT; Forbes G; VanDyke DH; Pearce FJ
    Trans Am Neurol Assoc; 1981; 106():199-202. PubMed ID: 7348994
    [No Abstract]   [Full Text] [Related]  

  • 19. Selection of analgesics in the treatment of the rheumatic disorders.
    Hart FD
    Proc R Soc Med; 1969 Jun; 62(6):539-40. PubMed ID: 5306583
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of tests on the efficacy of Edan (Polfa) in rheumatic and pararheumatic diseases].
    Szymański AF
    Przegl Lek; 1970 Sep; 26(9):728-30. PubMed ID: 5312080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.